Economic Considerations For REMSByEdgar Adams, ScD, Robin Carter, Heather Raschtschenia,Tom Noto, Covance Periapproval ServicesJune 13th 2009Drug sponsors have options in both how the new FDA risk programs are structured and how to execute them